Skip to main navigation
Instil Bio logo
  • Home
  • News & Events
    • News Releases
    • Events
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Proxy Materials
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact IR

News Releases

September 19, 2022
Instil Bio to Present at Jefferies Cell and Genetic Medicine Summit
September 9, 2022
Instil Bio to Present at Morgan Stanley Global Healthcare Conference
September 6, 2022
Instil Bio Announces Appointment of Tim Moore as Chief Operating Officer
August 12, 2022
Instil Bio Reports Second Quarter 2022 Financial Results and Provides Corporate Update
May 27, 2022
Instil Bio Announces IND Clearance of First CoStAR-TIL program, ITIL-306, Designed to Enhance Activity in the Tumor Microenvironment
May 18, 2022
Instil Bio to Present Novel TIL Analytics at American Society of Gene and Cell Therapy (ASGCT)
May 16, 2022
Instil Bio Reports First Quarter 2022 Financial Results and Provides Corporate Update
March 7, 2022
Instil Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
March 2, 2022
Instil Bio to Present at the Cowen 42nd Annual Health Care Conference

Investor Tools

Instil Bio Instil Bio

Footer Menu

  • About
  • Careers
  • Pipeline
  • Contact Us
  • Publications

Site Social Media Links

  • LinkedIn LinkedIn
  • Twitter Twitter
© 2022 Instil Bio. All Rights Reserved
Privacy Policy Terms of Service Agency Policy